Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03951792 · ClinicalTrials.gov registry record
Time Longitudinal Study of the Microbiome in Colorectal Cancer Subjects
A clinical trial of Gastrointestinal Disease and Cancer Colon, sponsored by Mayo Clinic.
- Completed
- Registry status
- 220
- Enrollment target
- 1
- Study location
NCT03951792: Completed study of Gastrointestinal Disease and Cancer Colon, sponsored by Mayo Clinic.
NCT03951792 is a study of Gastrointestinal Disease and Cancer Colon that has completed, run by Mayo Clinic. The registered enrollment target is 220 participants, below the 2,385-participant average among 7 other Gastrointestinal Disease trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03951792, a study of Gastrointestinal Disease and Cancer Colon, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 220 participants
- Enrollment target
- 1
- Study location
Study Summary
Researchers are trying to determine whether certain microbiome cause cancer or whether they are part of the microbiome in the gut due to the presence of cancer.
Primary Outcome
Biomarkers will be defined by extracting DNA/RNA from tissue biopsies and stored for specific gene extractions.
Conditions Studied
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2019-05-28 |
| Est. Completion | 2024-03-15 |
What the finished NCT03951792 record still lists
NCT03951792 is an observational study that tracks outcomes without assigning an intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap, below the 2,385-participant average among 7 other Gastrointestinal Disease trials with a reported enrollment target (91% lower).
The record links to 2 conditions, with Gastrointestinal Disease appearing as the primary indexed condition, and to 0 interventions.
NCT03951792 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT03951792 about?
NCT03951792 is a clinical study titled "Time Longitudinal Study of the Microbiome in Colorectal Cancer Subjects". Researchers are trying to determine whether certain microbiome cause cancer or whether they are part of the microbiome in the gut due to the presence of cancer.
What is the current status of trial NCT03951792?
This trial is currently completed. The enrollment target is 220 participants. The study started on 2019-05-28. Estimated completion is 2024-03-15.
What conditions does trial NCT03951792 study?
This clinical trial studies the following conditions: Gastrointestinal Disease, Cancer Colon.
Who is sponsoring clinical trial NCT03951792?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03951792 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastrointestinal Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Advancing Nursing Practices in Hospital Oncology Care
ACTIVE NOT RECRUITING · NA
-
Pilot Study for Evaluation of Cryobiopsy and Correlation With Standard Forceps Biopsy
ACTIVE NOT RECRUITING · NA
-
Optimizing Gastrointestinal Procedure Appointments
COMPLETED · NA
-
Clinical Evaluation of Water Immersion Colonoscopy Insertion Technique
COMPLETED · NA
-
FDG-PET-CT and Biomarkers in Esophageal Cancer
COMPLETED · NA
-
Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®)
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00920972 · 220 participants · Phase 1
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
- NCT01851642 · 220 participants
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
- NCT02582021 · 220 participants
WISE CVD - Continuation (WISE HFpEF)
- NCT04067830 · 220 participants · Phase 2
Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI